KDM3B Predicts Expression Signature, Prognosis Value, and Immune Characteristics of Cancers: A Pan‐Cancer Analysis
BioMed Research International · 2026-01 · 2026 (1)
DOI: 10.1155/bmri/6916290 ↗Kurz gefasst
Fachartikel in der Zeitschrift BioMed Research International, online erschienen am 26.04.2026. Verfasst von Liping Zhu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Fujian Children's Hospital (Fujian Branch of Shanghai Children's Medical Center), College of Clinical Medicine for Obstetrics and Gynecology and Pedi…. Hauptthemen laut MEDLINE: Jumonji Domain-Containing Histone Demethylases, Neoplasms, Gene Expression Regulation, Neoplastic. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Research Fund Project of Fujian Maternal and Child Health Hospital, Natural Science Foundation of Fujian Province, Province-Level Special Subsidy Funds for Health in Fujian Province.
Abstract (Originalsprache)
Dysregulation of histone modifications contributes to the development of cancer. The loss of methylation on histone H3 and H4 and the loss of acetylation serve as indicators of tumors. Histone demethylase KDM3B, which contains a JmjC domain, plays an important role in tumorigenesis and development by removing H3K9me1/2 methylation. It also has a significant impact on regulating different types of cancer. KDM3B′s role in prognosis and tumor formation in cancer has not been thoroughly studied. In this study, we analyzed KDM3B expression data from the TCGA database in a pan‐cancer analysis. Our results show that KDM3B is highly expressed in many cancer types and is closely associated with poor prognosis. KDM3B expression is associated with immune checkpoint activities, lymphocyte infiltration, and immune landscape changes, suggesting that KDM3B could be a target for cancer therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Fujian Children's Hospital (Fujian Branch of Shanghai Children's Medical Center), College of Clinical Medicine for Obstetrics and Gynecology and Pediatrics, Fujian Medical University, Fuzhou, Fujian, China, fjmu.edu.cn.
- Medical Research Center, Fujian Maternity and Child Health Hospital, College of Clinical Medicine for Obstetrics and Gynecology and Pediatrics, Fujian Medical University, Fuzhou, Fujian, China, fjmu.edu.cn.
- Fujian Key Laboratory of Women and Children's Critical Diseases Research, Fujian Maternity and Child Health Hospital (Fujian Women and Children's Hospital), Fuzhou, Fujian, China.
ORCID-Profile: Liping Zhu, Xiaoyan Peng, Haile Yu, Xiaolu Fan, Zhoujie Ye
Förderung
- Research Fund Project of Fujian Maternal and Child Health Hospital
- Natural Science Foundation of Fujian Province
- Province-Level Special Subsidy Funds for Health in Fujian Province
- Joint Funds for the Innovation of Science and Technology, Fujian Province
- National Natural Science Foundation of China
Zitieren
APA
Zhu, L., Peng, X., Yu, H., Fan, X., & Ye, Z. (2026). KDM3B Predicts Expression Signature, Prognosis Value, and Immune Characteristics of Cancers: A Pan‐Cancer Analysis. BioMed Research International, 2026(1). https://doi.org/10.1155/bmri/6916290
Vancouver
Zhu L, Peng X, Yu H, Fan X, Ye Z. KDM3B Predicts Expression Signature, Prognosis Value, and Immune Characteristics of Cancers: A Pan‐Cancer Analysis. BioMed Research International. 2026;2026(1). doi:10.1155/bmri/6916290
BibTeX
@article{Zhu2026,
author = {Zhu, Liping and Peng, Xiaoyan and Yu, Haile and Fan, Xiaolu and Ye, Zhoujie},
title = {KDM3B Predicts Expression Signature, Prognosis Value, and Immune Characteristics of Cancers: A Pan‐Cancer Analysis},
journal = {BioMed Research International},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/bmri/6916290}
}
EUVIMED